These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 15003531)

  • 1. Actinohivin, a novel anti-human immunodeficiency virus protein from an actinomycete, inhibits viral entry to cells by binding high-mannose type sugar chains of gp120.
    Chiba H; Inokoshi J; Nakashima H; Omura S; Tanaka H
    Biochem Biophys Res Commun; 2004 Mar; 316(1):203-10. PubMed ID: 15003531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Essential regions for antiviral activities of actinohivin, a sugar-binding anti-human immunodeficiency virus protein from an actinomycete.
    Takahashi A; Inokoshi J; Chiba H; Omura S; Tanaka H
    Arch Biochem Biophys; 2005 May; 437(2):233-40. PubMed ID: 15850563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The high mannose-type glycan binding lectin actinohivin: dimerization greatly improves anti-HIV activity.
    Takahashi A; Inokoshi J; Hachiya A; Oka S; Omura S; Tanaka H
    J Antibiot (Tokyo); 2011 Aug; 64(8):551-7. PubMed ID: 21694730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actinohivin: specific amino acid residues essential for anti-HIV activity.
    Takahashi A; Inokoshi J; Tsunoda M; Suzuki K; Takenaka A; Sekiguchi T; Omura S; Tanaka H
    J Antibiot (Tokyo); 2010 Nov; 63(11):661-5. PubMed ID: 20842142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Actinohivin, a broadly neutralizing prokaryotic lectin, inhibits HIV-1 infection by specifically targeting high-mannose-type glycans on the gp120 envelope.
    Hoorelbeke B; Huskens D; Férir G; François KO; Takahashi A; Van Laethem K; Schols D; Tanaka H; Balzarini J
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3287-301. PubMed ID: 20498311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyanovirin-N, a potent human immunodeficiency virus-inactivating protein, blocks both CD4-dependent and CD4-independent binding of soluble gp120 (sgp120) to target cells, inhibits sCD4-induced binding of sgp120 to cell-associated CXCR4, and dissociates bound sgp120 from target cells.
    Mori T; Boyd MR
    Antimicrob Agents Chemother; 2001 Mar; 45(3):664-72. PubMed ID: 11181340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actinohivin, a novel anti-HIV protein from an actinomycete that inhibits syncytium formation: isolation, characterization, and biological activities.
    Chiba H; Inokoshi J; Okamoto M; Asanuma S; Matsuzaki Ki ; Iwama M; Mizumoto K; Tanaka H; Oheda M; Fujita K; Nakashima H; Shinose M; Takahashi Y; Omura S
    Biochem Biophys Res Commun; 2001 Mar; 282(2):595-601. PubMed ID: 11401502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AMD3465, a monomacrocyclic CXCR4 antagonist and potent HIV entry inhibitor.
    Hatse S; Princen K; De Clercq E; Rosenkilde MM; Schwartz TW; Hernandez-Abad PE; Skerlj RT; Bridger GJ; Schols D
    Biochem Pharmacol; 2005 Sep; 70(5):752-61. PubMed ID: 16011832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective interactions of the human immunodeficiency virus-inactivating protein cyanovirin-N with high-mannose oligosaccharides on gp120 and other glycoproteins.
    Shenoy SR; O'Keefe BR; Bolmstedt AJ; Cartner LK; Boyd MR
    J Pharmacol Exp Ther; 2001 May; 297(2):704-10. PubMed ID: 11303061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance of human immunodeficiency virus type 1 to the high-mannose binding agents cyanovirin N and concanavalin A.
    Witvrouw M; Fikkert V; Hantson A; Pannecouque C; O'keefe BR; McMahon J; Stamatatos L; de Clercq E; Bolmstedt A
    J Virol; 2005 Jun; 79(12):7777-84. PubMed ID: 15919930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissecting carbohydrate-Cyanovirin-N binding by structure-guided mutagenesis: functional implications for viral entry inhibition.
    Barrientos LG; Matei E; Lasala F; Delgado R; Gronenborn AM
    Protein Eng Des Sel; 2006 Dec; 19(12):525-35. PubMed ID: 17012344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4.
    Zhao Q; Ma L; Jiang S; Lu H; Liu S; He Y; Strick N; Neamati N; Debnath AK
    Virology; 2005 Sep; 339(2):213-25. PubMed ID: 15996703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent inhibition of HIV-1 fusion by cyanovirin-N requires only a single high affinity carbohydrate binding site: characterization of low affinity carbohydrate binding site knockout mutants.
    Chang LC; Bewley CA
    J Mol Biol; 2002 Apr; 318(1):1-8. PubMed ID: 12054763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How can (-)-epigallocatechin gallate from green tea prevent HIV-1 infection? Mechanistic insights from computational modeling and the implication for rational design of anti-HIV-1 entry inhibitors.
    Hamza A; Zhan CG
    J Phys Chem B; 2006 Feb; 110(6):2910-7. PubMed ID: 16471901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The characteristic structure of anti-HIV actinohivin in complex with three HMTG D1 chains of HIV-gp120.
    Zhang F; Hoque MM; Jiang J; Suzuki K; Tsunoda M; Takeda Y; Ito Y; Kawai G; Tanaka H; Takénaka A
    Chembiochem; 2014 Dec; 15(18):2766-73. PubMed ID: 25403811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marked depletion of glycosylation sites in HIV-1 gp120 under selection pressure by the mannose-specific plant lectins of Hippeastrum hybrid and Galanthus nivalis.
    Balzarini J; Van Laethem K; Hatse S; Froeyen M; Van Damme E; Bolmstedt A; Peumans W; De Clercq E; Schols D
    Mol Pharmacol; 2005 May; 67(5):1556-65. PubMed ID: 15718224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple and multivalent interactions of novel anti-AIDS drug candidates, sulfated polymannuronate (SPMG)-derived oligosaccharides, with gp120 and their anti-HIV activities.
    Liu H; Geng M; Xin X; Li F; Zhang Z; Li J; Ding J
    Glycobiology; 2005 May; 15(5):501-10. PubMed ID: 15616125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational study of the dynamics of mannose disaccharides free in solution and bound to the potent anti-HIV virucidal protein cyanovirin.
    Margulis CJ
    J Phys Chem B; 2005 Mar; 109(8):3639-47. PubMed ID: 16851402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble gC1q-R/p33, a cell protein that binds to the globular "heads" of C1q, effectively inhibits the growth of HIV-1 strains in cell cultures.
    Szabó J; Cervenák L; Tóth FD; Prohászka Z; Horváth L; Kerekes K; Beck Z; Bácsi A; Erdei A; Peerschke EI; Füst G; Ghebrehiwet B
    Clin Immunol; 2001 May; 99(2):222-31. PubMed ID: 11318594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of HIV entry by carbohydrate-binding proteins.
    Balzarini J
    Antiviral Res; 2006 Sep; 71(2-3):237-47. PubMed ID: 16569440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.